Articles
How retractions are helping cancer research
Retraction Watch was born as a blog to unveil the reasons behind the retraction of a paper. It is now a comprehensive database helping to foster a better quality of…
Right drug, wrong patient: here’s how we improve our targeting
Most of the revolutionary techniques now used to investigate cancers, their development and response to treatments were already ‘old news’ by the time Balkees Abderrahman entered cancer research. Currently a…
How to make precision drugs that work better
Six lessons from the development of the first targeted anti-cancer therapy Why are today’s precision drugs falling so short of the impact achieved by tamoxifen, the first ever targeted cancer…
AI will help Cinderella to see herself in the mirror
Almost three in ten patients who undergo breast reconstruction after cancer surgery are unhappy with the results. This may be due to objective failures, but often dissatisfaction comes from unrealistic…
The unique toxicities of CAR-T cell therapy
Toxicities related to CAR T cell therapy are very different from the toxic side effects associated with classical chemotherapy or targeted therapy. Oncologists need to know what to look out…
Tackling resistance to anti-EGFR therapies, from challenges to re-challenge
New technologies and innovative approaches can help preventing and overcome innate or acquired resistance to EGFR inhibitors, improving their therapeutic effects Since their first approval and use, more than 15…